Accrued Liabilities and Other Payables (Details) - USD ($)		Dec. 31, 2019	Dec. 31, 2018
Payables and Accruals [Abstract]
Accrued payroll liability		$ 373,083	$ 529,472
Accrued professional fees		1,243,190	166,077
Accrued research and development fees	[1]	650,000
Insurance payable			45,088
Accrued directors' compensation		115,000	17,500
Accounts payable		84,316	6,695
Interest payable			75,342
Other		104,595	120,017
Total accounts payable and accrued liabilities		$ 2,570,184	$ 960,191

[1] In accordance with the strategic partnership agreement with Weill Cornell's cGMP Cellular Therapy Facility and Laboratory signed on August 6, 2018, the Company provides $400,000 annually to Weill Cornell's cGMP Cellular Therapy Facility and Laboratory to support the co-development projects. In addition, the Company will on an annual basis send one scientist or clinician to Weill Cornell's cGMP Cellular Therapy Facility and Laboratory to receive relevant training for three to six months. As of December 31, 2019, the accrued and unpaid research and development fees related to this agreement was $150,000.